161 related articles for article (PubMed ID: 17697064)
1. Discordance between intramuscular triglyceride and insulin sensitivity in skeletal muscle of Zucker diabetic rats after treatment with fenofibrate and rosiglitazone.
Nadeau KJ; Ehlers LB; Aguirre LE; Reusch JE; Draznin B
Diabetes Obes Metab; 2007 Sep; 9(5):714-23. PubMed ID: 17697064
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
[TBL] [Abstract][Full Text] [Related]
3. Exercise training and calorie restriction increase SREBP-1 expression and intramuscular triglyceride in skeletal muscle.
Nadeau KJ; Ehlers LB; Aguirre LE; Moore RL; Jew KN; Ortmeyer HK; Hansen BC; Reusch JE; Draznin B
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E90-8. PubMed ID: 16449296
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin.
Metais C; Forcheron F; Abdallah P; Basset A; Del Carmine P; Bricca G; Beylot M
Metabolism; 2008 Jul; 57(7):946-53. PubMed ID: 18555836
[TBL] [Abstract][Full Text] [Related]
5. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
[TBL] [Abstract][Full Text] [Related]
7. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
Laurent D; Gounarides JS; Gao J; Boettcher BR
Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
[TBL] [Abstract][Full Text] [Related]
8. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
[TBL] [Abstract][Full Text] [Related]
9. [Effects of fenofibrate on gene expression of carnitine palmitoyltransferase 1 in liver and skeletal muscle and its influence on insulin sensitivity].
Bai XP; Li HL; Yang WY; Xiao JZ; Wang B; Du RQ; Lou DJ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):268-70. PubMed ID: 18361841
[TBL] [Abstract][Full Text] [Related]
10. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
Kim SK; Zhao ZS; Lee YJ; Lee KE; Kang SM; Choi D; Lim SK; Chung N; Lee HC; Cha BS
Diabetes Metab Res Rev; 2003; 19(6):487-93. PubMed ID: 14648808
[TBL] [Abstract][Full Text] [Related]
11. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
12. A combination of CLA-DAG oil modifies the diabetic phenotype in male Zucker diabetic fatty rats.
Iqbal MJ; Higginbotham A; Chickris N; Bollaert M; Rockway S; Banz WJ
Horm Metab Res; 2008 Apr; 40(4):262-8. PubMed ID: 18548385
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.
Chakrabarti R; Misra P; Vikramadithyan RK; Premkumar M; Hiriyan J; Datla SR; Damarla RK; Suresh J; Rajagopalan R
Eur J Pharmacol; 2004 May; 491(2-3):195-206. PubMed ID: 15140637
[TBL] [Abstract][Full Text] [Related]
14. Postexercise muscle triacylglycerol and glycogen metabolism in obese insulin-resistant zucker rats.
Bruce CR; Lee JS; Kiens B; Hawley JA
Obes Res; 2004 Jul; 12(7):1158-65. PubMed ID: 15292481
[TBL] [Abstract][Full Text] [Related]
15. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
[TBL] [Abstract][Full Text] [Related]
16. Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats.
Chirieac DV; Collins HL; Cianci J; Sparks JD; Sparks CE
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E42-9. PubMed ID: 14970003
[TBL] [Abstract][Full Text] [Related]
17. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet.
Fernandes-Santos C; Carneiro RE; de Souza Mendonca L; Aguila MB; Mandarim-de-Lacerda CA
Nutrition; 2009; 25(7-8):818-27. PubMed ID: 19268533
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor subtype-specific regulation of hepatic and peripheral gene expression in the Zucker diabetic fatty rat.
Dana SL; Hoener PA; Bilakovics JM; Crombie DL; Ogilvie KM; Kauffman RF; Mukherjee R; Paterniti JR
Metabolism; 2001 Aug; 50(8):963-71. PubMed ID: 11474486
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
Endo M; Masaki T; Seike M; Yoshimatsu H
Exp Biol Med (Maywood); 2007 May; 232(5):614-21. PubMed ID: 17463157
[TBL] [Abstract][Full Text] [Related]
20. PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats.
Zhao X; Li LY
Am J Nephrol; 2008; 28(4):598-606. PubMed ID: 18277067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
